Profile data is unavailable for this security.
About the company
Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.
- Revenue in BRL (TTM)4.25bn
- Net income in BRL346.73m
- Incorporated1964
- Employees16.70k
- LocationFleury SAAv. General Valdomiro de Lima508, JabaquaraSAO PAULO 04.344-070BrazilBRA
- Phone+55 1 150351986
- Fax+55 1 150147425
- Websitehttp://www.fleury.com.br/
More ▼
Mergers & acquisitions
| Acquired company | FLRY3:SAO since announced | Transaction value |
|---|---|---|
| Instituto Hermes Pardini SA | 35.90% | 485.11m |
| Marcelo Magalhaes Diagnosticos SA | -10.72% | -- |
| Laboratorio Marcelo Magalhaes SA | -10.72% | 70.41m |
Data delayed at least 15 minutes, as of Oct 06 2022 15:15 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kora Saude Participacoes SA | 1.74bn | -83.33m | 1.90bn | 4.50k | -- | 1.51 | 118.62 | 1.09 | -0.135 | -0.135 | 2.53 | 1.62 | 0.4449 | 15.72 | 3.12 | -- | -1.78 | -- | -2.20 | -- | 25.27 | -- | -4.01 | -- | 1.58 | 1.19 | 0.6463 | -- | 106.09 | -- | -501.47 | -- | -- | -- |
| Centro de Imagem Diagnosticos SA | 1.11bn | -55.22m | 2.49bn | -- | -- | 2.16 | 34.66 | 2.24 | -0.4686 | -0.4686 | 9.41 | 9.72 | 0.4264 | 67.45 | 5.53 | -- | -1.80 | 0.2191 | -2.28 | 0.273 | 31.96 | 26.77 | -4.22 | 0.4881 | 0.8062 | 0.5239 | 0.4876 | -- | 22.37 | 3.62 | 94.23 | -- | -0.9897 | -- |
| Instituto Hermes Pardini SA | 2.05bn | 194.06m | 2.82bn | 7.10k | 14.00 | 2.89 | 8.58 | 1.38 | 1.53 | 1.53 | 16.21 | 7.44 | 0.9489 | 25.16 | 4.59 | 288,721.10 | 9.01 | 9.83 | 12.32 | 13.07 | 29.01 | 29.72 | 9.49 | 10.51 | 0.9799 | 268.37 | 0.3665 | 32.09 | 32.92 | 17.16 | 68.79 | 15.75 | 24.53 | -- |
| Oncoclinicas do Brasil Srvcs Mdcs SA | 3.16bn | 104.78m | 3.19bn | -- | 30.21 | 1.76 | 11.47 | 1.01 | 0.2115 | 0.2115 | 6.37 | 3.64 | 0.6623 | 25.62 | 4.04 | -- | 2.80 | -- | 4.01 | -- | 34.14 | -- | 4.22 | -- | 1.91 | 2.22 | 0.5169 | -- | 32.77 | -- | 70.62 | -- | -- | -- |
| Hospital Mater Dei Sa | 1.31bn | 121.05m | 3.34bn | 3.68k | 22.77 | 1.99 | 17.32 | 2.56 | 0.3821 | 0.3821 | 3.76 | 4.38 | 0.369 | 19.53 | 3.30 | -- | 3.76 | -- | 4.18 | -- | 36.63 | -- | 10.18 | -- | 2.88 | 3.74 | 0.5264 | -- | 42.69 | -- | 99.49 | -- | -- | -- |
| Odontoprev SA | 1.85bn | 446.01m | 5.02bn | 2.03k | 11.24 | 4.21 | 9.84 | 2.71 | 0.7828 | 0.7828 | 3.24 | 2.09 | 0.9103 | 179.22 | 13.28 | -- | 21.91 | 21.67 | 34.15 | 30.70 | 62.06 | 60.29 | 24.07 | 21.48 | 0.7308 | -- | 0.0398 | 61.27 | 4.37 | 6.15 | 5.33 | 11.98 | 30.90 | 5.95 |
| Fleury SA | 4.25bn | 346.73m | 5.64bn | 16.70k | 16.18 | 3.09 | 7.22 | 1.33 | 1.09 | 1.09 | 13.39 | 5.73 | 0.7052 | 41.18 | 5.27 | 265,527.30 | 5.80 | 6.96 | 7.57 | 8.43 | 28.40 | 29.53 | 8.22 | 10.63 | 1.35 | 3.35 | 0.6633 | 75.72 | 30.32 | 13.06 | 36.18 | 8.87 | 17.57 | -4.79 |
| Diagnosticos da America SA | 11.86bn | -176.54m | 10.61bn | 18.14k | -- | 1.41 | 11.78 | 0.8945 | -0.3014 | -0.3014 | 20.50 | 13.33 | 0.5539 | 20.99 | 4.58 | -- | -0.8154 | 0.1711 | -1.07 | 0.2218 | 29.20 | 30.79 | -1.47 | 0.2926 | 1.21 | 1.13 | 0.6221 | 1,170.85 | 48.01 | 27.93 | -50.24 | -- | 22.42 | 42.34 |
Data as of Oct 06 2022. Currency figures normalised to Fleury SA's reporting currency: Brazilian Real BRL
15.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bram Bradesco Asset Management S/A DTVMas of 31 May 2022 | 7.68m | 2.41% |
| The Vanguard Group, Inc.as of 09 Sep 2022 | 7.46m | 2.35% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2022 | 5.54m | 1.74% |
| Handelsbanken Fonder ABas of 31 Aug 2022 | 5.18m | 1.63% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 08 Sep 2022 | 4.86m | 1.53% |
| APG Asset Management NVas of 31 Dec 2021 | 4.58m | 1.44% |
| Van Eck Associates Corp.as of 08 Sep 2022 | 3.98m | 1.25% |
| RBC Global Asset Management (UK) Ltd.as of 29 Jul 2022 | 3.84m | 1.21% |
| BlackRock Fund Advisorsas of 08 Sep 2022 | 3.03m | 0.95% |
| Capital Research & Management Co. (International Investors)as of 30 Jun 2022 | 2.83m | 0.89% |
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
